Paper36137752
Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
Morath C and 32 others. J Am Soc Nephrol, 2023. Cited by 11 papers, by iCite.
Cite this record
ConductScience Library. Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients. Papers, record 36137752. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36137752
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Induction of Long-Lasting Regulatory B Lymphocytes by Modified Immune Cells in Kidney Transplant Recipients.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Kidney Transplantation | Major topic |
| B-Lymphocytes, Regulatory | Major topic |
| Humans | |
| Immunosuppressive Agents | |
| Immunosuppression Therapy | |
| Immune Tolerance | |
| Transplant Recipients |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02560220 | MIC Cell Therapy for Individualized Immunosuppression in Living Donor Kidney Transplant Recipients | Derived from the trial | Yes |
Source ClinicalTrials.gov
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Comment in | 36719144 | Immune Modulatory Cell Therapy in Kidney Transplantation: Hints of a Durable Mechanism of Action. | https://conductscience.org/library/papers/36719144 |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 11 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41283510 | Influence and Role of Regulatory B Cells in Organ Transplantation: The State of the Art, Prospects, and Emerging Insights. | Antibodies (Basel) | 2025 | https://conductscience.org/library/papers/41283510 | PubMed |
| 41210169 | Protocol of generation of tolerogenic dendritic cells affects their transcriptional and metabolic profiles leading to specific tolerogenic functions. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/41210169 | PubMed |
| 41007627 | Anti-B Cell Strategy in Nephrotic Syndrome: Beyond Rituximab. | Biomedicines | 2025 | https://conductscience.org/library/papers/41007627 | PubMed |
| 40264774 | Regulatory B cells, the key regulator to induce immune tolerance in organ transplantation. | Front Immunol | 2025 | https://conductscience.org/library/papers/40264774 | PubMed |
| 40035907 | Frontiers and Controversies in De Novo Gastrointestinal Tumors After Organ Transplantation: Current Progress and Future Directions. | Ann Surg Oncol | 2025 | https://conductscience.org/library/papers/40035907 | PubMed |
| 38393856 | The balance between memory and regulatory cell populations in kidney transplant recipients with operational tolerance. | Clin Exp Immunol | 2024 | https://conductscience.org/library/papers/38393856 | PubMed |
| 37483623 | Five-year follow-up of a phase I trial of donor-derived modified immune cell infusion in kidney transplantation. | Front Immunol | 2023 | https://conductscience.org/library/papers/37483623 | PubMed |
| 36368749 | Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial. | BMJ Open | 2022 | https://conductscience.org/library/papers/36368749 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD19 | 930 | PubTator's text mining | https://conductscience.org/library/genes/930 | NCBI Gene |
| CD24 | 100133941 | PubTator's text mining | https://conductscience.org/library/genes/100133941 | NCBI Gene |
| CD38 | 952 | PubTator's text mining | https://conductscience.org/library/genes/952 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36137752
GET https://conductscience.org/api/papers/v1/36137752/authors?page=2